As Money Pours Into Weight Loss Drugs, Physicians Prioritize Efficacy, Access

As high prices and supply issues drive consumers to alternative markets for GLP-1s, physicians aren’t too interested in using these therapies to treat conditions like heart disease risk that have existing cheap standards of care.